[ET Net News Agency, 7 January 2026] HANSOH PHARMA (03692) rose 4.7% to HK$40.38.
It hits an intra-day high of HK$40.58, breaking above the 20-D SMA of HK$39.247, and an
intra-day low of HK$38. The total shares traded was 36.81 million, with a value of
HK$1.4b. The active buy/sell ratio is 62:38, with net buying turnover of HK$50.44m. CHINA
INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$4.13m,
with volume weighted average price of HK$39.788. MERRILL LYNCH FE accounts for greatest
net responsive selling turnover of HK$27.77m, with volume weighted average price of
HK$39.604. The stock has risen a combined 11.9% over the past 4 consecutive trading days.
The Hang Seng Index now fell 257 points, or 1% to 26,452.

Basic Information
=================

---------------------------------
Nominal 40.380 % Chg +4.67%
High 40.580 Low 38.000
Shares Tr 36.81m Turnover 1.4b
10-D SMA 37.674 %H.V 38.887
20-D SMA 39.247 VWAP 38.072
50-D SMA 38.576 RSI14 59.075
---------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 62:38, with net buying
turnover of HK$50.44m, rising a combined 11.9% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 40.38 +4.67
CSPC PHARMA (01093) 9.09 +2.60
SINO BIOPHARM (01177) 6.69 +1.67
HENGRUI PHARMA (01276) 77.90 +4.49
INNOVENT BIO (01801) 86.55 +2.43
FOSUN PHARMA (02196) 20.56 -0.77
WUXI BIO (02269) 35.08 +2.87
WUXI APPTEC (02359) 109.20 +3.21
BEONE MEDICINES (06160) 198.10 +3.02
AKESO (09926) 126.80 +5.32
-----------------------------------------------
(ed)